Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice - Wikidata - awgldk - TriplyDB

Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice

Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice

http://www.wikidata.org/entity/Q34181298

about

The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections Diagnostic and therapeutic applications of lytic phages Photodynamic therapy: a new antimicrobial approach to infectious disease?Adjunctive Application of Antimicrobial Photodynamic Therapy in Nonsurgical Periodontal Treatment: A Review of Literature Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii Bacteriophage therapy of a Vibrio parahaemolyticus infection caused by a multiple-antibiotic-resistant O3:K6 pandemic clinical strain.Biodiversity of vibrios.Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.Influence of environmental variables in the efficiency of phage therapy in aquaculture Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.Complete genome sequence of Vibrio vulnificus bacteriophage SSP002 Complete genome sequence of bacteriophage VvAW1, which infects Vibrio vulnificus Antibacterial nanomedicine.Microneedle-mediated transdermal bacteriophage delivery.Bacteriophage biocontrol in animals and meat products.Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.Bacteriophage and their lysins for elimination of infectious bacteria.Vibrio vulnificus bacteriophage SSP002 as a possible biocontrol agent.Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.Phage therapy: eco-physiological pharmacology.Phage approved in food, why not as a therapeutic?Application of host-specific bacteriophages to the surface of chicken skin leads to a reduction in recovery of Campylobacter jejuni.Transfersomal Phage Cocktail Is an Effective Treatment against Methicillin-Resistant Staphylococcus aureus-Mediated Skin and Soft Tissue Infections.Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K.Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.Can phage effectively treat multidrug-resistant plague?Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia.Bacteriophage recombineering in the lytic state using the lambda red recombinases.Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release.Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle.Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages.Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis.Isolation and characterization of broad spectrum bacteriophages lytic to Vibrio harveyi from shrimp farms of Kerala, India.Evaluation of the influence of bacteriophage titer on the treatment of colibacillosis in broiler chickens.

P2860

Q21131311-71C3281A-751B-4F91-9265-399E39B56608 Q23920569-C1FCDA9A-3149-4F6F-8597-503362E33F65 Q24626076-F8F2581E-FDAE-4BE8-AB9C-F095E81423D3 Q26782456-EF3D1759-0070-474E-9BF7-38A09FE28E2A Q28390950-BB8CF206-B8F4-4E42-8DEC-6ADC92376432 Q28394377-97260ADC-6802-45CC-B263-1A2AA8C87F11 Q28484243-A3965D29-028E-4CBE-9050-0397C20F89D2 Q30359301-F29CFC60-6C46-4A0B-8238-45ABA36803AC Q31110190-99E1AE6C-C6E7-46C0-BA94-138851AD9EDD Q33622945-4642EE2F-5209-4048-BE42-46CD03EE3234 Q33798541-A17D3014-0595-4341-8334-ECA66A748ABB Q34498214-E8ADC2C9-8C95-41E5-B156-36E6D437995F Q35023248-8C9BA228-3BF6-411D-8E63-05D71C4EE0C4 Q35124495-A7629F90-728D-4DBC-A884-6BFFD617E81E Q36155402-9381FAE1-3D93-4A23-8716-3E5382795D8D Q36573717-4AF069B3-F532-4B3C-9483-7810F15677B2 Q37176392-CC18BD6B-3361-419B-AB24-42F4D18CFAA0 Q37187438-F949C5BF-2FAA-453A-B34D-3DA2AB98499C Q37273445-363F1F28-4D2F-433E-A2F9-7F9D5AC03004 Q37335751-F0526FAC-89DE-42B1-A340-A5159BB6AD9F Q37389925-9CA2822B-9C4C-4BD0-A447-B4180BC0BF6E Q37470848-D1B71AA6-F49E-4FE0-A8D6-D0BA5913C628 Q37545535-CE18C964-D0D8-4EE7-BF09-35812776EAD7 Q37928694-88E49100-EA48-451C-95D4-FB86871A71A3 Q38230407-917B74A5-737D-4A57-9CBF-AAA9CD16BFDF Q38285489-2FA10B80-1ACC-4B8D-B1E2-C69AA7BD6577 Q39913513-F17F5C60-91FF-413B-9F51-E990F3E18DF4 Q40121755-13AC8772-6D9E-445B-B2D2-6B8EDC99B3C7 Q40129903-39E22E24-F18D-4ED4-98C8-3264165BD476 Q40301589-AB6047FD-C107-4337-890E-3B4D0BE242DE Q41092030-8AA75CC2-64B2-4ED4-8C7F-9B8C0725DA1A Q41402927-4571DAF8-3739-4E74-A28A-2AB2E1D77D28 Q41531194-B394702D-B849-4727-9319-E37FED38BB48 Q41873720-C5FA3499-55E3-4634-8117-3097E5F13F1B Q41918244-5279131B-06FC-4802-A05C-7FA470BF9A6B Q42209007-110888D8-A23F-4C01-A9F3-077DF0D6AB4B Q42231153-5A1912E9-B298-4F96-B1E9-8470F2F70A83 Q42241966-29F0E942-AC00-43D1-81EE-9EF9D1EFD58C Q42262099-AB37548E-960E-482A-893D-EFF555F8F16F Q43856464-47BA8800-6720-41AC-B996-A9AAC2AF7042

P2860

Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice

http://www.wikidata.org/entity/Q34181298

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@ast

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@en

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@nl

type

label

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@ast

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@en

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@nl

prefLabel

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@ast

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@en

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@nl

P1433

Q34181298-8B03E002-9350-46CD-AD66-7B0B27769107

P1476

Q34181298-01FD1717-1239-4050-B9AA-B9FEC240CDD2

P2093

Q34181298-AA540B84-60B6-4568-A255-AC974C9727D9

Q34181298-ABA2D764-569D-419A-B1D5-3C4050AF6AAC

Q34181298-F4412F23-9F61-4FFC-87B3-2543B754FC3D

Q34181298-FB4E1A46-E1C6-4D19-8105-53CB6A808E79

P2860

Q34181298-040E7E1B-5FD5-4E73-9E48-2417B0E2B371

Q34181298-05C12586-F895-4B90-846E-1D1228A7C8F2

Q34181298-09C944AA-A7D0-4244-BA09-7AE153D7F9DB

Q34181298-0E651F0E-9BEE-427F-9398-F594F16ED3F4

Q34181298-0FDE6516-C570-4CEF-8A05-8C92883A3E3D

Q34181298-132B85EE-6768-4EBE-8594-34BA88E54BF9

Q34181298-1BDBDD43-0FD1-448D-A48D-56B17ED0E16E

Q34181298-1E50F883-F351-43A7-8EEC-C67AB74D1A18

Q34181298-2430813B-3D3F-4202-8178-A040C8D97A0C

Q34181298-27C12222-668E-4831-8AEA-8B4EC8FCE892

P304

Q34181298-83D9D71A-7880-4E4D-9F6C-5E2DE10C1D5C

P31

Q34181298-BA4E4CB5-1E5F-4BAA-B39B-2C7724A78DF2

P356

Q34181298-A0C3E510-2F30-4723-AA70-2DF173C8B0E2

P407

Q34181298-A83C14A3-8B25-46AA-8041-271EFAB358AF

P433

Q34181298-30489B84-2E47-44E8-B7EB-8C1EE7C45BBD

P478

Q34181298-FB0FB816-5689-4CF6-81C4-C71140D7E1B6

P577

Q34181298-35AA21A9-B7C1-4B95-A7A8-6B095933BAFB

P698

Q34181298-A23DDFEE-C82B-4D47-92BD-973C83835F62

P932

Q34181298-55D2E541-2683-4484-8F26-7C0E21EC23D5

P356

IAI.70.11.6251-6262.2002

P1433

Infection and Immunity

P1476

Phage therapy of local and sys ...... s in iron-dextran-treated mice

@en

P2093

Angelo DePaola

http://www.w3.org/2001/XMLSchema#string

Donna H Duckworth

http://www.w3.org/2001/XMLSchema#string

Karen E Cerveny

http://www.w3.org/2001/XMLSchema#string

Paul A Gulig

http://www.w3.org/2001/XMLSchema#string

P2860

Bacteriophage therapy

The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded mice

Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Construction and phenotypic evaluation of a Vibrio vulnificus vvpE mutant for elastolytic protease.

Pathogenesis of Vibrio vulnificus.

Epidemiology and pathogenesis of Vibrio vulnificus.

Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control

Metalloprotease is not essential for Vibrio vulnificus virulence in mice

Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin

Phages infecting Vibrio vulnificus are abundant and diverse in oysters (Crassostrea virginica) collected from the Gulf of Mexico

P304

6251-6262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.70.11.6251-6262.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12379704

http://www.w3.org/2001/XMLSchema#string

P932

130292

http://www.w3.org/2001/XMLSchema#string